REQUEST A DEMO
Total
USD $0.00
Search more companies

Mcg Pharma Ilac San. Ve Tic. Ltd. Sti. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Mcg Pharma Ilac Sanayi Ve Ticaret Limited Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Mcg Pharma Ilac San. Ve Tic. Ltd. Sti. is a company based in Turkiye, with its head office in Ankara. It operates in the Pharmaceutical Preparation Manufacturing sector. It was established on June 20, 2017. It currently has a total number of 37 (2025) employees. There was a net sales revenue increase of 682.89% reported in Mcg Pharma Ilac San. Ve Tic. Ltd. Sti.’s latest financial highlights for 2023. During that time, Mcg Pharma Ilac San. Ve Tic. Ltd. Sti.’s total assets grew by 224.22%. The net profit margin of Mcg Pharma Ilac San. Ve Tic. Ltd. Sti. increased by 0.02% in 2023.

Headquarters
Atb Is Merkezi No:1/1/29 Macun Mahallesi Bati Bulvari Yenimahalle
Ankara; Central Anatolia; Postal Code: 06370

Contact Details: Purchase the Mcg Pharma Ilac San. Ve Tic. Ltd. Sti. report to view the information.

Website: http://www.pharmamcg.com

Basic Information
Total Employees:
Purchase the Mcg Pharma Ilac San. Ve Tic. Ltd. Sti. report to view the information.
Financial Auditors:
Purchase the Mcg Pharma Ilac San. Ve Tic. Ltd. Sti. report to view the information.
Incorporation Date:
June 20, 2017
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Mcg Pharma Ilac San. Ve Tic. Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
682.89%
Total operating revenue
682.89%
Operating profit (EBIT)
166.55%
Net Profit (Loss) for the Period
1170.52%
Total assets
224.22%
Total equity
291.79%
Operating Profit Margin (ROS)
-2.27%
Net Profit Margin
0.02%
Return on Equity (ROE)
0.14%
Debt to Equity Ratio
-21.23%
Quick Ratio
-1.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?